CSNK2A1 Foundation
3-way NDA for data sharing
Accelerates rare disease therapy by sharing drug repurposing hit lists across orgs.
Posted September 8, 2025
Work & Deliverables
We are seeking a lawyer to draft a clear and balanced three-party Non-Disclosure Agreement (NDA) between patient organizations. The NDA will specifically cover the exchange of confidential research data, including prioritized “hit lists” from drug repurposing screens.The volunteer lawyer’s deliverables will include:Drafting a legally sound 3-way NDA template that addresses confidentiality, permitted use of data, restrictions on sharing, and dispute resolution.Ensuring the NDA includes mutual protections for all three organizations, rather than favoring one party.Providing plain-language explanations of key clauses so patient organization leaders (who may not have legal backgrounds) can clearly understand their obligations.Delivering a finalized, ready-to-sign document that can be executed by each organization.Offering brief guidance on any related considerations (e.g., data governance, intellectual property rights).
CSNK2A1 Foundation
CSNK2A1 Foundation is focused on finding a cure for Okur-Chung Neurodevelopmental Syndrome and ensuring affected individuals have the opportunities and supports necessary for happy and full lives.
CSNK2A1 Foundation
CSNK2A1 Foundation is focused on finding a cure for Okur-Chung Neurodevelopmental Syndrome and ensuring affected individuals have the opportunities and supports necessary for happy and full lives.